# The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2023, Regulation 15: Amendment of regulation 19C


In regulation 19C (fees for assessment of post-authorisation safety studies)—
(a) in paragraph (2)—
(i) in sub-paragraph (a), for “£734” substitute “£1,308”,
(ii) in sub-paragraph (b), for “£8,309” substitute “£9,140”,
(iii) in sub-paragraph (c), for “£734” substitute “£1,308”, and
(b) in paragraph (3)—
(i) in sub-paragraph (a), for “£734” substitute “£1,308”,
(ii) in sub-paragraph (b), for “£8,309” substitute “£9,140”, and
(iii) in sub-paragraph (c), for “£734” substitute “£1,308”.

---
Source: https://www.legislation.gov.uk/uksi/2023/314/regulation/15 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2023/regulation-15
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.